Group leader positions in London

RESEARCH GROUP LEADER POSITIONS AT LRI, moving to the FRANCIS CRICK INSTITUTE in 2015

The Cancer Research UK London Research Institute is currently recruiting Junior Group Leaders. The LRI is the largest research institute funded by Cancer Research UK, the largest independent cancer research organisation in Europe. Its research focusses on the analysis of fundamental biological processes involved in cancer. The Institute’s international staff work in 50 research groups at the Institute’s two London laboratory sites at Clare Hall (South Mimms) or Lincoln’s Inn Fields (central London).

In 2015 the LRI will be absorbed into the new Francis Crick Institute, housed in a state-of-the-art laboratory building currently under construction at St Pancras, London. The Crick will use interdisciplinary approaches to investigate the biology of human health and disease, and will work with scientists and research institutions across the UK. In addition to researchers from LRI, the Crick’s research portfolio – some 1500 researchers in over 120 research groups – will be developed from the MRC National Institute for Medical Research, and three London universities: UCL, King’s College London, and Imperial College London.

These positions thus offer a tremendous opportunity for an ambitious young scientist to establish a world-class research programme in an interactive and supportive environment. LRI research groups are extremely well supported: there is no requirement to obtain external grant funding, there are no teaching responsibilities, and we benefit from centrally funded cutting-edge core technology facilities.

LRI is focussed on the broad area of cancer biology, and particularly interested in the following fields:

Tumour Biology: tumour-host interactions, cancer models, human cancer genomics
Genome integrity: Chromosome Biology, DNA damage, Cell Cycle regulation
Computational Biology: Bioinformatics, biological networks, image processing

Applications should be submitted online.

Deadline November 30.